Sign in Subscribe

/ 2 items

#PYPD↓

FDA Grants Priority Review to PolyPid’s D-PLEX100 for Surgical Infection Prevention

PYPD/ 07/29/2026 · 9:56 AM

FDA Grants Priority Review to PolyPid’s D-PLEX100 for Surgical Infection Prevention

PDUFA date set for Nov 28, 2026, triggering $15M milestone.

PolyPid Secures $320 Million Partnership with Azurity for D-PLEX100 in U.S. and Canada

PYPD/ 07/21/2026 · 3:53 PM

PolyPid Secures $320 Million Partnership with Azurity for D-PLEX100 in U.S. and Canada

Roth Capital maintains a Buy rating with a $9 price target despite the post-deal share decline.